Engineering:Journal of Commercial Biotechnology
From HandWiki
Short description: Academic journal
|Subject |Discipline}} | Biotechnology |
---|---|
Language | English |
Publication details | |
History | 1992 to present |
Publisher | thinkBiotech (US) |
Standard abbreviations | |
ISO 4 | J. Commer. Biotechnol. |
Indexing | |
ISSN | 1462-8732 (print) 1478-565X (web) |
Links | |
The Journal of Commercial Biotechnology is a peer-reviewed academic journal covering the business of biotechnology. Topics covered include biotechnology management, policy, finance, law, and regulations.
The Journal of Commercial Biotechnology was founded by Henry Stewart Publications in 1992 as the Journal of Biotechnology in Healthcare,[1] and changed its name to the Journal of Commercial Biotechnology in 1998.[2] The journal was later published by Palgrave MacMillan[3] and was purchased by thinkBiotech[4] in 2010. It is published quarterly. An external Editorial Board assists with peer review. The current editor of the Journal of Commercial Biotechnology is Yali Friedman, who has served since 2007.
References
- ↑ "Business profile for kumclibrary.org provided by Network Solutions". Archived from the original. Error: If you specify
|archiveurl=
, you must also specify|archivedate=
. https://web.archive.org/web/20120325223758/http://www.kumclibrary.org/vufind/Record/106453/Description. - ↑ Journal of Commercial Biotechnology. WorldCat. OCLC 41491559. https://www.worldcat.org/oclc/41491559.
- ↑ "IngentaConnect Publication: Journal of Commercial Biotechnology". http://www.ingentaconnect.com/content/pal/jcb.
- ↑ "ThinkBiotech Global biopharmaceutical innovation expert speaker - Yali Friedman, Ph.D.". http://thinkbiotech.com/#products.
External links